Literature DB >> 23528295

Synthesis of indolyl-3-acetonitrile derivatives and their inhibitory effects on nitric oxide and PGE2 productions in LPS-induced RAW 264.7 cells.

Tae Hoon Kwon1, Ik Hwan Yoon, Ji-Sun Shin, Young Hun Lee, Bong Jin Kwon, Kyung-Tae Lee, Yong Sup Lee.   

Abstract

Arvelexin is one of major constituents of Brassica rapa that exerts anti-inflammatory activities. Several indolyl-3-acetonitrile derivatives were synthesized as arvelexin analogs and evaluated for their abilities to inhibit NO and PGE2 productions in LPS-induced RAW 264.7 cells. Of the indolyl-3-acetonitriles synthesized, compound 2k, which possesses a hydroxyl group at C-7 position of the indole ring and an N-methyl substituent, more potently inhibited NO and PGE2 productions and was less cytotoxic than arvelexin on macrophage cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23528295     DOI: 10.1016/j.bmcl.2013.02.114

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Isatis tinctoria L.-derived Petroleum Ether Extract Mediates Anti-inflammatory Effects via Inhibition of Interleukin-6, Interleukin-33 and Mast Cell Degranulation.

Authors:  Tobias Lotts; Kathrin Kabrodt; Johanna Hummel; Dorit Binder; Ingo Schellenberg; Sonja Ständer; Konstantin Agelopoulos
Journal:  Acta Derm Venereol       Date:  2020-05-11       Impact factor: 3.875

2.  Screening of NO Inhibitor Release Activity from Soft Coral Extracts Origin Palu Bay, Central Sulawesi, Indonesia.

Authors:  Wendy Alexander Tanod; Uun Yanuhar; Masteria Yunovilsa Putra; Yenny Risjani
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2019

Review 3.  From Suppressor T cells to Regulatory T cells: How the Journey That Began with the Discovery of the Toxic Effects of TCDD Led to Better Understanding of the Role of AhR in Immunoregulation.

Authors:  Narendra Prasad Singh; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.